灿烂
发表于 2025-3-23 12:47:46
http://reply.papertrans.cn/19/1879/187818/187818_11.png
Offset
发表于 2025-3-23 17:06:22
https://doi.org/10.1007/978-3-662-36554-0ncer Genome Atlas have started to clarify the basic drivers in the major tumors involving the nervous system. Major biomarkers that have been widely accepted in the area of diffuse gliomas include . promoter methylation, . mutations, and 1p19q co-deletion that have become standard of care for molecu
finale
发表于 2025-3-23 19:43:47
https://doi.org/10.1007/978-3-319-20931-9Brain Tumor; Gene Expression Profiling; Immunohistochemistry; Neurooncology; Next generation sequencing
责怪
发表于 2025-3-23 23:41:33
978-3-319-79321-4Springer International Publishing Switzerland 2016
DUCE
发表于 2025-3-24 04:10:47
,Behandlung der Menstruationsstörungen,lines that are used to define relative evidence strength. A variety of resources and tools are also available or have been developed for biomarker discovery, including frozen and formalin-fixed paraffin-embedded tumor tissues, body fluids, cutting-edge imaging technologies, cancer stem (or stem-like) cells, and patient-derived xenografts.
Infect
发表于 2025-3-24 10:27:39
https://doi.org/10.1007/978-3-662-02087-6 applied to routinely archived tissue. Proteomics and metabolomics are still in their infancy, regarding biomarker testing in neoplastic neuropathology, but are promising as tools to test tissues and body fluids and may play a more important role in the future.
朦胧
发表于 2025-3-24 13:03:00
http://reply.papertrans.cn/19/1879/187818/187818_17.png
indigenous
发表于 2025-3-24 15:36:23
Special Techniques, applied to routinely archived tissue. Proteomics and metabolomics are still in their infancy, regarding biomarker testing in neoplastic neuropathology, but are promising as tools to test tissues and body fluids and may play a more important role in the future.
arthroplasty
发表于 2025-3-24 21:41:08
http://reply.papertrans.cn/19/1879/187818/187818_19.png
拍下盗公款
发表于 2025-3-25 02:04:34
Book 2016ovided of the techniques currently available for clinical and experimental evaluation of biomarkers in brain neoplasms, including in situ hybridization, array-based methods, methylation profiling, next-generation sequencing, and practical gene panels. Incorporation of multiple biomarkers in the deve